Presentation is loading. Please wait.

Presentation is loading. Please wait.

Microbial Risk Assessment

Similar presentations


Presentation on theme: "Microbial Risk Assessment"— Presentation transcript:

1 Microbial Risk Assessment
Global Water Sanitation and Health Mark D. Sobsey and Lisa Casanova Spring, 2007

2 WHO Health-Risk Based Framework: Application to WHS
These principles apply to all types of WSH activities

3 WHO Health-Risk Based Framework: Application to WHS
A risk-based framework Source-to-consumer management approach to protection from exposure to environmental agents Establishes health based-targets for control (specific microbes and chemicals) Sets acceptable level of risk appropriate to setting and population Helps establish and carry out Management Plans (Safety Plans) to achieve control Includes independent surveillance Is an integrated, proactive approach Consistent across, compatible with and applicable to all WSH measures

4 Quantitative Microbial Risk Assessment: The Definition
Applications of the principles of risk assessment to the estimation of the consequences from anticipated or actual exposure to infectious microorganisms

5 Exposure, Level of Protection and Microbial Risk: The Relationship
= Confidence Region or Interval Risk  Exposure   Level of Protection (e.g., technologic control)

6 Important Differences Between Microbial & Chemical Risks: The Microbial
A single microbe (one unit) is infectious and can cause dramatic effects Microbes multiply in a host (increases adverse effects) Microbes multiply in environmental media (some microbes) Microbes are capable of secondary spread Can infect a host from an environmental route of exposure (water, food, etc.) Can then spread to other hosts by person-to-person transmission Some microbes cause a wide range (spectrum) of adverse effects Microbes can change: mutate, evolve, adapt, change gene expression, etc.

7 Important Differences Between Microbial & Chemical Risks: the Chemical
Unique and specific structures that define (predict) activities Many molecules may be required for an effect; gradation of effects Do not multiply/reproduce No secondary spread Accumulation and compartmentalization Metabolism and chemical reactivity Detoxification Threshold (no adverse effect level) Cumulative effects Magnitude of exposure influences magnitude of adverse effects and their appearance/manifestation Distinctive health effects based on chemical reactions with specific molecules, tissues and organs

8 Quantitative Risk Assessment for Agents from Environmental Sources: a Conceptual Framework
Adapted from: National Academy of Sciences - National Research Council framework by US EPA and the International Life Sciences Institute (ILSI)

9 Risk Management and Communication
RISK ASSESSMENT FOR ENVIRONMENTALLY TRANSMITTED PATHOGENS: ILSI/EPA PARADIGM PROBLEM FORMULATION: HAZARD IDENTIFICATION CHARACTERIZATION OF EXPOSURE EFFECTS CHARACTERIZATION OF HUMAN HEALTH EFFECTS RISK CHARACTERIZATION Risk Management and Communication

10 ILSI/EPA Risk Assessment Framework and Steps: Analysis Phase

11 QRA for Agents from Environmental Sources: Steps in the Conceptual Framework

12 Conducting Hazard Identification for Microbes
Identify microbe(s) that is (are) the causative agent(s) of disease Develop/identify diagnostic tools to: identify symptoms identify infection isolate causative microbe in host specimens identify causative microbe in host specimens Understand the disease process from exposure to infection, illness (pathophysiology) and death Identify transmission routes Identify transmission scenarios

13 Conducting Hazard Identification for Microbes
Assess virulence factors and other properties of the microbe responsible for disease, including life cycle Identify and apply diagnostic tools to determine incidence and prevalence in populations and investigate disease outbreaks Develop models (usually animals) to study disease process and approaches to treatment Evaluate role of immunity in overcoming/preventing infection and disease and possible vaccine development Study epidemiology of microbe associated with exposure scenarios

14 QRA for Agents from Environmental Sources: Steps in the Conceptual Framework

15 Purpose: determine the quantity or dose
Exposure Assessment Purpose: determine the quantity or dose Dose = number, quantity or amount of microorganisms corresponding to a single exposure (e.g., by ingestion) Average or typical dose A measure of central tendency (mean or median) Distribution of doses microbe quantity varies in time and space described as a probability or frequency distribution a probability density function

16 CHARACTERIZATION OF EXPOSURE - ELEMENTS INCLUDED IN PATHOGEN CHARACTERIZATION: OCCURRENCE
Temporal distribution, duration and frequency Concentration in food or environmental media Spatial distribution clumping, aggregation, association with particles, clustering Niche ecology and non-human reservoirs: Where are they in the environment and what other host harbors them? potential to multiply/survive in specific media

17 Survival, persistence, and amplification Seasonality
CHARACTERIZATION OF EXPOSURE - ELEMENTS INCLUDED IN PATHOGEN CHARACTERIZATION: OCCURRENCE Survival, persistence, and amplification Seasonality Meteorological and climatic events Presence of control or treatment processes reliability and variability of processes Indicators/surrogates for indirect evaluation predictive of pathogen

18 ELEMENTS CONSIDERED IN PATHOGEN CHARACTERIZATION
Virulence and pathogenicity of the microorganism Pathologic characteristics and diseases caused Survival and multiplication of the microorganism Resistance to control or treatment processes Host specificity Infection mechanism and route; portal of entry Potential for secondary spread Taxonomy and strain variation Ecology and natural history

19 Pathogen Characteristics or Properties Favoring Environmental Transmission
KEY: Multiple sources and high endemicity (continued presence) in humans, animals and environment High concentrations released into or present in environmental media (water, food, air, etc.) High carriage rate in human and animal hosts Asymptomatic carriage in non-human hosts Ability to proliferate in water and other media Ability to adapt to and persist in different media or hosts Seasonality and climatic effects Natural and anthropogenic sources

20 Pathogen Characteristics or Properties Favoring Environmental Transmission
Ability to persist or proliferate in environment Ability to survive or penetrate treatment processes Stable environmental forms spores, cysts, oocysts, stable outer viral layer (protein coat), bacterial capsule (outer polysaccharide layer), etc. Resistance to biodegradation, heat, cold (freezing), drying, dessication, UV light, ionizing radiation, pH extremes, etc. Resists proteases, amylases, lipases and nucleases Possesses DNA repair mechanisms and other injury repair processes Colonization, biofilm formation, resting stages, protective stages, parasitism Spatial distribution Aggregation, particle association, intercellular accumulation, etc.

21 Virulence Properties of Pathogenic Bacteria Favoring Environmental Transmission
Virulence properties: structures or chemical constituents that contribute to pathophysiology Outer cell membrane of Gram negative bacteria: an endotoxin (fever producer) Exotoxins: release toxic chemicals Pili: for attachment and effacement to cells and tissues Invasins: to facilitate cell invasion Effacement factors Spores highly resistant to physical and chemical agents very persistent in the environment plasmids, lysogenic bacteriophages, etc.

22 Pathogen Characteristics or Properties Favoring Environmental Transmission
Genetic properties favoring survival and pathogenicity Double-stranded DNA or RNA DNA repair Ability for genetic exchange, mutation and selection recombination plasmid exchange, transposition, conjugation, etc. point mutation reassortment gene expression control Virulence properties: expression, acquisition, exchange Antibiotic resistance

23 Role Emergence and Selection of New Microbial Strains on Exposure Risks
Antigenic changes in microbes can create changes that overcome immunity, increasing risks of re-infection or illness Antigenically different strains of microbes appear in hosts or are created in the environment; are selected for over time and space Constant selection of new strains by antigenic shift and drift Genetic recombination, reassortment , bacterial conjugation, bacteriophage infection or bacteria and point mutations Antigenic Shift in viruses: Major change in virus genetic composition by gene substitution or replacement (e.g., reassortment); Influena A viruses (e.g., H?N?)

24 Microbial mimicking of host antigens; e.g. malaria
Role Emergence and Selection of New Microbial Strains on Exposure Risks Antigenic Drift: Minor changes in genetic composition, often by mutation involving specific codons in existing genes (point mutations) A single point mutation can greatly alter microbial virulence Microbial mimicking of host antigens; e.g. malaria Antigens expressed by pathogen resemble host antigens; they can change

25 Other Pathogen Characteristics or Properties Favoring Environmental Transmission
Ability to Cause Infection and Illness Low infectious dose High probability of infection and illness from exposure to one or a few microbes Infects by multiple routes Ingestion: gastrointestinal (GI) Inhalation: respiratory Cutaneous: skin eye Other routes

26 Microbe Levels in Environmental Media Vary Over Time
Occurrence of Giardia Cysts in a Water: Cumulative Frequency Distribution

27 CHARACTERIZATION OF EXPOSURE: ELEMENTS CONSIDERED IN EXPOSURE ANALYSIS
Identification of water, food or other media/vehicles of exposure Units of exposure (e.g number of cells) Routes of exposure and transmission potential Size of exposed population Demographics of exposed population Spatial and temporal nature of exposure (single or multiple; intervals) Behavior of exposed population Treatment (e.g. of water), processing (e.g., of foods), and recontamination

28 QRA for Agents from Environmental Sources: Steps in the Conceptual Framework

29 CHARACTERIZATION OF HUMAN HEALTH EFFECTS: ELEMENTS OF HOST CHARACTERIZATION
Age Immune status Concurrent illness or infirmity Genetic background or status Pregnancy Nutritional status Demographics of the exposed population (density, movement or migration, etc.) Social and behavioral traits and conditions

30 Morbidity, mortality, sequelae of illness
CHARACTERIZATION OF HUMAN HEALTH EFFECTS: ELEMENTS OF HOST CHARACTERIZATION Infectivity Illness Duration of illness Severity of illness Morbidity, mortality, sequelae of illness Extent or amount of secondary spread Initial host from an environmental exposure spreads infection and illness to others Quality of life Chronicity or recurrence

31 Characteristics or Properties of Pathogens -Interactions with Hosts
Disease characteristics and spectrum Signs, symptoms, pathophysiology Persistence in hosts: Chronicity Persistence Recrudescence Sequelae and other post-infection health effects cancer, heart disease, arthritis, neurological effects Yes, some microbes can cause these conditions! Secondary spread

32 Elements That May be Included in Dose-Response Analysis
Statistical model(s) to analyze or quantify dose-response relationships probability of infection/illness as a function of microbe dose Human dose-response data Animal dose-response data Utilization of outbreak or intervention data Route of exposure or administration

33 Elements That May be Included in Dose-Response Analysis
Source and preparation of exposure material or inoculum Organism type and strain including virulence factors or other measures of pathogenicity Characteristics of the exposed population age, immune status, etc. Duration and multiplicity of exposure

34 Dose-Response Data and Probability of Infection for Human Rotavirus

35

36 Dose-Response Models and Extrapolation to Low Dose Range
Most dose-response data for microbes are for: high doses of the microbes few hosts Practicalities and cost limits Dosing hundreds or thousands of volunteers is not possible But, many people become ill during epidemics if we can be there, we can study them as “natural” experiments

37 Dose-Response Models and Extrapolation to Low Dose Range
Real world exposures to microbes from water, food and air are often much lower microbial doses than used in human volunteer studies It becomes necessary to extrapolate the dose-response relationship of human volunteer studies Extrapolation to the low dose range This is the range where there are no experimental data points having discrete values above zero from the low exposure doses a best-fit modelling approach is employed

38 Models Typically Applied in Microbial Dose-Response Analyses
Exponential model Pinfection = 1 - e-rx r = probability of infection x = mean concentration/dose Assumes organisms are distributed randomly (Poisson) approaches a linear model at low doses

39 Models Typically Applied in Microbial Dose-Response Analyses
Exponential (linear) model; two populations: one-hit kinetics, but two classes of human susceptibility to microbe or perhaps two form of microbes with different infectivity or illness risks Beta-Poisson: a distributed threshold model assumes Poisson distribution of microbes and a Beta-distributed probability of infection r is not a constant but a probability distribution (Beta-distribution) two variables in the model

40 Probabilities of Exposure and Infection
Pexp (j Dose) = Probability of having j pathogenic microbes in an ingested dose Pinf (j Inf) = Conditional probability of infection from j pathogens ingested

41 Probability of Exposure

42 Exponential Dose-Response Model

43 Beta-Poisson Dose-Response Model

44 Rotavirus Dose-Response Relationships: Experimental Data, Exponential Model and Beta-Poisson Model

45 Daily and Annual Risks of Various Outcomes from Exposure to Water Containing Rotaviruses
4 Rotaviruses per 1000 Liters

46 Volunteer Dose-Response Data for Norwalk Virus*
Dose (mL) # dosed # ill % ill 4 16 11 69 1 21 14 67 0.01 2 50 0.0001 *"1st passage NV": Dolin et al. 1972; Wyatt et al., 1974.

47 Norwalk Virus Dose-Response Analysis Using Alternative Models

48 Dose-Response Relationships for Various Waterborne Pathogens: Downward Extrapolation to Low-Dose Range

49 Comparing Risks of Disease Agents
Comparing chemical to microbial risks as well as among agents of each type Effects vary widely in severity, mortality rates and time scale of exposure Need to protect both quality and quantity of life WSH policy needs to be linked to overall public health policy Decision making process needs to take social and economic factors into account

50 Desirable attributes of an integrated measure of risk
Address probability, nature and magnitude of adverse health consequences Incorporate age and health status of those affected

51 DALYs as unit measures for health
Conceptually simple: health loss = N x D x S N = number of affected persons D = duration of adverse health effect S = measure for severity of the effect Disability Adjusted Life Years (DALYs) mortality: years of life lost (YLL) morbidity: years lived with disability (YLD) DALY = YLL + YLD

52 Hypothetical example Premature death Acute (infectious) disease
Residual disability

53 Key Question: How do we define health?
‘a state of complete physical, mental and social well-being, and not merely the absence of disease or infirmity’ (WHO charter, 1946) ‘the ability to cope with the demands of daily life’ (the Dunning Committee on Medical Cure and Care, 1991) the absence of disease and other physical or psychological complaints (NSCGP, 1999) On might define health accordingly to the WHO-charter; this defintion is very close to the definition of happiness; while others would prefer only responses that can be clearly defined by medical doctors. Of course in the context of diminishing health care budgets and growing health care needs. 27 5

54 Deriving severity weights
Global Burden of Disease Project Define 22 indicator conditions Use Person Trade Off method to elicit severity weights Panel of physicians and public health scientists Use scale of indicator conditions to attribute severity weights to other conditions Methodology also applied in other studies

55 Using Epidemiology for Microbial Risk Analysis
Problem Formulation what’s the problem? determine what infectious disease is posing a risk its clinical features causative agent routes of exposure/infection health effects

56 Using Epidemiology for Microbial Risk Analysis
Exposure Assessment how how much when where and why exposure occurs vehicles vectors doses loads

57 Using Epidemiology for Microbial Risk Analysis
Health Effects Assessment Human clinical trials for dose-response field studies of endemic and epidemic disease in populations

58 Using Epidemiology for Microbial Risk Analysis
Risk characterization Epidemiologic measurements and analyses of risk: relative risk risk ratios odds ratios regression models of disease risk dynamic models of population disease risk Other disease burden characterizations: relative contribution to overall disease burdens effects of prevention and control measures and interventions economic considerations (monetary cost of the disease, cost effectiveness of prevention and control measures)

59 Elements That May Be Considered in Risk Characterization
Evaluate health consequences of exposure scenario Risk description (event) Risk estimation (magnitude, probability) Characterize uncertainty/variability/confidence in estimates Conduct sensitivity analysis evaluate most important variables and information needs Address items in problem formulation (reality check) Evaluate various control measures and their effects on risk magnitude and profile Conduct decision analysis evaluate alternative risk management strategies

60 Types of Epidemiological Studies that Have Been Used in Risk Assessment for Waterborne Disease

61 Some More Epidemiological Terms and Concepts
Outbreaks: two or more cases of disease associated with a specific agent, source, exposure and time period Epidemic Curve (Epi-curve): Number of cases or other measure of the amount of illness in a population over time during an epidemic Describes nature and time course of outbreak Can estimate incubation time if exposure time is known Can give clues to modes of transmission: point source, common source, and secondary transmission

62 Some More Epidemiological Terms and Concepts: Epidemic Curves
# cases # cases Time Time Common Source Point Source

63 Databases for Quantification and Statistical Assessment of Disease - USA
National Notifiable Disease Surveillance System National Ambulatory Medical Care Survey International Classification of Disease (ICD) Codes Other Databases Special surveys Sentinel surveillance efforts Resources for disease surveillance vary greatly by country. WHO and other international health entities assist countries lacking capacity for disease surveillance to obtain such data in various ways Tracking is poor for some diseases, such as gastroenteritis and its specific causative agents (etiologies)

64 Additional Analyses of Health Effects: Health Effects Assessments
Health Outcomes of Microbial Infection Identification and diagnosis of disease caused by the microbe disease (symptom complex and signs) Acute and chronic disease outcomes mortality diagnostic tests Sensitive populations and effects on them Disease Databases and Epidemiological Data

65 Methods to Diagnose Infectious Disease
Symptoms (subjective: headache, pain) and Signs (objective: fever, rash, diarrhea) Clinical diagnosis: lab tests Detect causative organism in clinical specimens Detect other specific factors associated with infection Immune response Detect and assay antibodies Detect and assay other specific immune responses

66 Health Outcomes of Microbial Infection
Acute Outcomes Diarrhea, vomiting, rash, fever, etc. Chronic Outcomes Paralysis, hemorrhagic uremia, reactive arthritis, etc. Hospitalizations Deaths

67 Morbidity Ratios for Salmonella (Non-typhi)

68 Acute and Chronic Outcomes Associated with Microbial Infections

69 Outcomes of Infection Process to be Quantified
Exposure Infection Asymptomatic Infection Advanced Illness, Chronic Infections and Sequelae Disease Acute Symptomatic Illness: Severity and Debilitation Sensitive Populations Mortality Hospitalization

70 Health Effects Outcomes: E. coli O157:H7

71 Health Effects Outcomes: Campylobacter

72 Sensitive Populations
Infants and young children Elderly Immunocompromised Persons with AIDs Cancer patients Transplant patients Pregnant Malnourished

73 Mortality Ratios for Enteric Pathogens in Nursing Homes Versus General Population

74 Impact of Waterborne Outbreaks of Cryptosporidiosis on AIDS Patients

75 Mortality Ratios Among Specific Immunocompromised Patient Groups with Adenovirus Infection

76 Databases for Quantification and Statistical Assessment of Disease
National Notifiable Disease Surveillance System National Ambulatory Medical Care Survey International Classification of Disease (ICD) Codes Other Databases Special surveys Sentinel surveillance efforts

77 Waterborne Outbreak Attack Rates- USA

78 Waterborne Outbreak Hospitalizations - USA

79 Predicted Waterborne Cryptosporidiosis in NYC in AIDS Patients Compared to the General Population
Perz et al., 1998, Am. J. Epid., 147(3):

80 Waterborne Adenovirus: A Risk Assessment
Adapted from Crabtree et al. (Wat. Sci. Tech., Vol 35, No , 1997) Steps of the risk assessment framework using human adenoviruses in water

81 Step 1: Hazard Identification
Infection and clinical disease About 1/3 of known adenoviruses cause human illness A wide range of illnesses, involving several different organ systems pharyngitis pneumonia conjunctivitis gastroenteritis and intussusception hemorrhagic cystitis meningoencephalitis Diagnosed by culture and immunologic techniques

82 Step 1: Hazard Identification
The transmission routes Fecal oral route Makes waterborne transmission possible Contamination of water supplies with fecal waste, spread when others come in contact with water Inhalation of aerosols (sneezing, coughing) Proximity of individuals encourages transmission groups of military recruits, hospitals, day care centers, schools Virus is shed for extended periods in feces and respiratory secretions Encourages transmission: large window of opportunity for spread to others

83 Step 2: Exposure Assessment
Occurrence in the environment and in human populations Infected people shed virus for long periods Adenoviruses have been found in water Appear to be stable (survives and remains infectious) in seawater and tap water Spread via swimming pools (outbreak study) Exposure via recreational waters is possible Occur worldwide in sewage Appears to be stable in sewage Fecal oral transmission if drinking or recreational water becomes contaminated by sewage Adenoviruses seem to be particularly resistant to disinfection by ultraviolet light May be difficult to remove by water treatment processes

84 Step 3: Health Effects Assessment
Characteristics of illness Illnesses of varying severity from eye infection to brain infections and pneumonia Can have secondary spread, especially in crowded environments Secondary spread also seen in waterborne outbreaks Many serotypes and many illnesses, making prevention difficult Vaccination currently not available

85 Step 3: Health Effects Assessment
Susceptible populations The elderly Outbreaks in nursing homes: people in close proximity encourages spread Elderly may consume more water than other populations, increasing their risk of exposure to waterborne adenovirus Children Spread in schools and day care environments Children may be frequent users of recreational waters, increasing their risk of exposure Hygiene habits of small children in schools and daycares may encourage spread

86 Step 3: Health Effects Assessment: Dose Response Assessment
Relationship between dose of virus received and probability of illness Use data from a human volunteer study Inhalation of aerosols of adenovirus 4 Probability of illness calculated using the exponential model Pi = 1-exp(-rN) Pi = probability of illness N = number of viruses ingested or inhaled R = parameter calculated from experimental dose-response data

87 Step 3: Health Effects Assessment: Dose Response Assessment
Calculating r from dose-response data Dose of virus (infectious units) No. of volunteers exposed No. of volunteers infected 11 3 5 1 When N=11, Pi = 1 When N=5, Pi = 1 When N=1, Pi = (3/1), or Pi = 0.333 We can use this value to calculate the value of r

88 Step 3: Health Effects Assessment: Dose Response Assessment
Calculating R from dose-response data When N=1, Pi = (3/1), or Pi = 0.333 Pi = 1-exp(-rN) ln(0.667) = ln(exp(-r)) 0.333 = 1-exp(-r(1)) = -r 0.333 = 1-exp(-r) r = = -exp(-r) 0.667 = exp(-r)

89 Step 3: Health Effects Assessment: Dose Response Assessment
We have solved for a value of r specific to the dose-response relationship of this organism Using this value of r, we can determine the probability of infection, Pi, from any dose N Question: What is the dose N??

90 Step 3: Health Effects Assessment: Dose Response Assessment
For waterborne adenovirus, we must evaluate the exposure (remember exposure assessment) Two main routes of exposure Drinking water Recreational water In order to evaluate exposure, we need to know: How much water do people drink? How much recreational water are they exposed to? How many viruses are in these waters?

91 Step 3: Health Effects Assessment: Dose Response Assessment
We can gather these data from various sources Studies of adenovirus occurrence in environmental and drinking water Studies of people’s water consumption habits (it’s been done!) These data can then be used to calculate doses to feed into the model

92 Step 3: Health Effects Assessment: Dose Response Assessment
On average, people drink about 2L of water per day Data on the occurrence of adenoviruses in drinking water is limited There is data on the occurrence of other enteric viruses in drinking water We can use this data as a surrogate measure of adenovirus occurrence in water Estimate: enteric viruses can occur in drinking water at levels of 1 per 100L to 1 per 1000L

93 Step 3: Health Effects Assessment: Dose Response Assessment
On average, people will be exposed to about 30 mL of recreational freshwater per day (try not to swallow the swimming pool water!) There is some data on the occurrence of adenoviruses in environmental waters From a monitoring study of a by We can use this data as a surrogate measure of adenovirus occurrence in recreational water Estimate: adenovirus can be present in recreational water at levels of per 100L to 12.8 per 100L

94 Step 3: Health Effects Assessment: Dose Response Assessment
Risks from exposure to drinking water Assume: 2L per day 1 virus in every 1000L of drinking water Dose: viruses/day r = Pi = 1-exp( *0.002) Pi = 8.09×10-4

95 Step 3: Health Effects Assessment: Dose Response Assessment
Therefore, the daily probability of infection from exposure to drinking water with 1 virus per 1000L = 8.09×10-4 This is the probability of infection, not illness To determine the probability of illness, we need a value for the fraction of infected individuals who will actually become clinically ill This will be unique for each organism

96 Step 3: Health Effects Assessment: Dose Response Assessment
The morbidity rate (fraction of infected individuals who actually become clinically ill) for adenovirus is 0.5 We can multiply the probability of infection from the model by this value to determine the probability of illness We can also calculate the probability of death if we know the fraction of ill people who will die from their illness (for adenovirus, value=0.01%)

97 Example: Daily risks from adenovirus in drinking water
Assume: 2L per day 1 virus in every 1000L of drinking water Probability of illness in the infected = 0.5 Probability of death in the ill = 0.01% Risk of infection 8.09×10-4 Risk of illness 4.05×10-4 Risk of death 4.05×10-8

98 Example: Yearly risks from adenovirus in drinking water
Knowing the daily risks, we can also calculate these risks over a period of a year using the equation: Pyear = 1- (1- Pi)365 Risk of infection 2.56×10-1 Risk of illness 1.37×10-1 Risk of death 1.48×10-5

99 Step 3: Health Effects Assessment: Dose Response Assessment
We now know the daily and yearly risks from waterborne adenovirus in drinking water at a level of 1 virus per 1000L The same model can be used to assess risk for other levels of adenovirus in water The model can also be applied in exactly the same way to recreational water risks

100 Step 4: Risk Characterization
Using the dose-response relationship and exponential model, we now have information about the risks from waterborne adenovirus Risk from drinking water and recreational water Risk from different amounts of virus in these water sources Daily risks and yearly risks Risk of infection, illness, and death What can we do with this information?

101 Step 4: Risk Characterization
Compare the values to predetermined benchmarks of acceptable risk Example: EPA recommends that the risk of infection from drinking water should not exceed 1 in 10,000 per year Risk levels from our models exceed this risk Suggests that waterborne adenovirus in water poses an unacceptable risk to consumers

102 Step 4: Risk Characterization
What can be done about this? First: determine the dose of adenovirus that does not exceed the 1:10,000/year benchmark This can be done using the model (Pi = 10-4) How do we ensure that people’s exposure does not exceed this dose? Evaluating water treatment efficacy Does water treatment reduce adenovirus levels below the level of acceptable risk? How do we improve treatment to achieve acceptable levels of risk? Changes in water treatment practices


Download ppt "Microbial Risk Assessment"

Similar presentations


Ads by Google